|
1
|
Ljungberg B, Bensalah K, Canfield S,
Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L,
Merseburger AS, et al: EAU guidelines on renal cell carcinoma: 2014
update. Eur Urol. 67:913–924. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Udager AM and Mehra R: Morphologic,
molecular and taxonomic evolution of renal cell carcinoma: A
conceptual perspective with emphasis on updates to the 2016 world
health organization classification. Arch Pathol Lab Med.
140:1026–1037. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gnarra JR, Tory K, Weng Y, Schmidt L, Wei
MH, Li H, Latif F, Liu S, Chen F, Duh FM, et al: Mutations of the
VHL tumour suppressor gene in renal carcinoma. Nat Genet. 7:85–90.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Varela I, Tarpey P, Raine K, Huang D, Ong
CK, Stephens P, Davies H, Jones D, Lin ML, Teague J, et al: Exome
sequencing identifies frequent mutation of the SWI/SNF complex gene
PBRM1 in renal carcinoma. Nature. 469:539–542. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li G, Chong T, Xiang X, Yang J and Li H:
Downregulation of microRNA-15a suppresses the proliferation and
invasion of renal cell carcinoma via direct targeting of eIF4E.
Oncol Rep. 38:1995–2002. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jin L, Li Y, Liu J, Yang S, Gui Y, Mao X,
Nie G and Lai Y: Tumor suppressor miR-149-5p is associated with
cellular migration, proliferation and apoptosis in renal cell
carcinoma. Mol Med Rep. 13:5386–5392. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Y, Chen D, Jin LU, Liu J, Li Y, Su Z,
Qi Z, Shi M, Jiang Z and Yang S: Oncogenic microRNA-142-3p is
associated with cellular migration, proliferation and apoptosis in
renal cell carcinoma. Oncol Lett. 11:1235–1241. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang Z, Li Y, Fan L, Zhao Q, Tan B, Li Z
and Zang A: microRNA-425-5p is upregulated in human gastric cancer
and contributes to invasion and metastasis in vitro and
in vivo. Exp Ther Med. 9:1617–1622. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun L, Jiang R, Li J, Wang B, Ma C, Lv Y
and Mu N: MicoRNA-425-5p is a potential prognostic biomarker for
cervical cancer. Ann Clin Biochem. 54:127–133. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vaira V, Roncalli M, Carnaghi C, Faversani
A, Maggioni M, Augello C, Rimassa L, Pressiani T, Spagnuolo G, Di
Tommaso L, et al: MicroRNA-425-3p predicts response to sorafenib
therapy in patients with hepatocellular carcinoma. Liver Int.
35:1077–1086. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hao JF, Ren KM, Bai JX, Wang SN, Shao B,
Cao N and Li X: Identification of potential biomarkers for clear
cell renal cell carcinoma based on microRNA-mRNA pathway
relationships. J Cancer Res Ther. 10:Suppl. C167–C177. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ge YZ, Xin H, Lu TZ, Xu Z, Yu P, Zhao YC,
Li MH, Zhao Y, Zhong B, Xu X, et al: MicroRNA expression profiles
predict clinical phenotypes and prognosis in chromophobe renal cell
carcinoma. Sci Rep. 5:103282015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang X, Liu Y, Cao G, Zhang X, Xu H, Xu H
and Wang J: Expression of the EphA1 protein is associated with
Fuhrman nuclear grade in clear cell renal cell carcinomas. Int J
Clin Exp Pathol. 8:6821–6827. 2015.PubMed/NCBI
|
|
15
|
Moch H, Artibani W, Delahunt B, Ficarra V,
Knuechel R, Montorsi F, Patard JJ, Stief CG, Sulser T and Wild PJ:
Reassessing the current UICC/AJCC TNM staging for renal cell
carcinoma. Eur Urol. 56:636–643. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qian H, Deng X, Huang ZW, Wei J, Ding CH,
Feng RX, Zeng X, Chen YX, Ding J, Qiu L, et al: An HNF1α-regulated
feedback circuit modulates hepatic fibrogenesis via the crosstalk
between hepatocytes and hepatic stellate cells. Cell Res.
25:930–945. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Inui M, Martello G and Piccolo S: MicroRNA
control of signal transduction. Nat Rev Mol Cell Biol. 11:252–263.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peng WZ, Ma R, Wang F, Yu J and Liu ZB:
Role of miR-191/425 cluster in tumorigenesis and diagnosis of
gastric cancer. Int J Mol Sci. 15:4031–4048. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang J, Li Z, Ge Q, Wu W, Zhu Q, Luo J and
Chen L: Characterization of microRNA transcriptome in tumor,
adjacent and normal tissues of lung squamous cell carcinoma. J
Thorac Cardiovasc Surg. 149:1404–1414, e1404. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Di Leva G, Piovan C, Gasparini P, Ngankeu
A, Taccioli C, Briskin D, Cheung DG, Bolon B, Anderlucci L, Alder
H, et al: Estrogen mediated-activation of miR-191/425 cluster
modulates tumorigenicity of breast cancer cells depending on
estrogen receptor status. PLoS Genet. 9:e10033112013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Y, Hu X, Miao X, Zhu K, Cui S, Meng
Q, Sun J and Wang T: MicroRNA-425-5p regulates chemoresistance in
colorectal cancer cells via regulation of Programmed Cell Death 10.
J Cell Mol Med. 20:360–369. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fang F, Song T, Zhang T, Cui Y, Zhang G
and Xiong Q: MiR-425-5p promotes invasion and metastasis of
hepatocellular carcinoma cells through SCAI-mediated dysregulation
of multiple signaling pathways. Oncotarget. 8:31745–31757.
2017.PubMed/NCBI
|
|
25
|
Di Pietro V, Ragusa M, Davies D, Su Z,
Hazeldine J, Lazzarino G, Hill LJ, Crombie N, Foster M and Purrello
M: MicroRNAs as novel biomarkers for the diagnosis and prognosis of
mild and severe traumatic brain injury. J Neurotrauma.
34:1948–1956. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ren RJ, Zhang YF, Dammer EB, Zhou Y, Wang
LL, Liu XH, Feng BL, Jiang GX, Chen SD, Wang G and Cheng Q:
Peripheral blood microrna expression profiles in alzheimer's
disease: screening, validation, association with clinical phenotype
and implications for molecular mechanism. Mol Neurobiol.
53:5772–5781. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gao Y, Yin Y, Xing X, Zhao Z, Lu Y, Sun Y,
Zhuang Z, Wang M, Ji W and He Y: Arsenic-induced anti-angiogenesis
via miR-425-5p-regulated CCM3. Toxicol Lett. 254:22–31. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Buck SB, Bradford J, Gee KR, Agnew BJ,
Clarke ST and Salic A: Detection of S-phase cell cycle progression
using 5-ethynyl-2′-deoxyuridine incorporation with click chemistry,
an alternative to using 5-bromo-2′-deoxyuridine antibodies.
Biotechniques. 44:927–929. 2008. View Article : Google Scholar : PubMed/NCBI
|
